Clinical Trials Directory

Trials / Unknown

UnknownNCT00412438

Investigation of Genetic Risk of Atrial Fibrillation

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (planned)
Sponsor
Nagoya University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The atrial fibrillation (AF) is the most common cardiac rhythm disturbance that is responsible for substantial morbidity and mortality independent of associated heart disease or other risk factors. Even in the absence of preexisting cardiovascular disease, AF remains significantly associated with excess mortality rates. The current unsatisfactory treatment for AF comes from lack of understanding of the pathophysiology of AF. The purpose of this study is to identify gene polymorphisms that confer susceptibility to atrial fibrillation. Patients with AF(N=500) and healthy volunteer(N=1000) without AF are enrolled in this study. Patients with coronary artery disease, severe valvular heart disease, cardiomyopathy or heart failure were excluded from the study.

Conditions

Timeline

Start date
2006-10-01
First posted
2006-12-18
Last updated
2006-12-18

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00412438. Inclusion in this directory is not an endorsement.

Investigation of Genetic Risk of Atrial Fibrillation (NCT00412438) · Clinical Trials Directory